Register for real-time alerts, custom portfolio, and market movers

Get Started

ABBV

AbbVie (ABBV)

AbbVie Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:ABBV

<< Previous 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 Next >>

Date	Time	Source	Headline	Symbol	Company
05/11/2021	5:07PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/11/2021	5:07PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/11/2021	5:06PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/11/2021	5:06PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/11/2021	5:05PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/10/2021	5:01PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ABBV	AbbVie Inc
05/10/2021	9:22AM	Dow Jones News	AbbVie's Allergan Aesthetics to Buy Soliton	NYSE:ABBV	AbbVie Inc
05/10/2021	8:30AM	PR Newswire (US)	Allergan Aesthetics to Acquire Soliton, Expanding Body Contouring Portfolio	NYSE:ABBV	AbbVie Inc
05/10/2021	8:30AM	PR Newswire (US)	Allergan Aesthetics to Acquire Soliton, Expanding Body Contouring Portfolio	NYSE:ABBV	AbbVie Inc
05/05/2021	4:25PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/04/2021	3:40PM	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	NYSE:ABBV	AbbVie Inc
05/04/2021	3:42AM	TipRanks	AbbVie Raises EPS Guidance After 1Q Earnings Beat	NYSE:ABBV	AbbVie Inc
04/30/2021	8:27AM	Dow Jones News	AbbVie Raises Full-Year Guidance	NYSE:ABBV	AbbVie Inc
04/30/2021	8:26AM	Dow Jones News	AbbVie Posts 1Q Revenue Growth on Broad-Based Sales Acceleration	NYSE:ABBV	AbbVie Inc
04/30/2021	7:45AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ABBV	AbbVie Inc
04/30/2021	7:42AM	PR Newswire (US)	AbbVie Reports First-Quarter 2021 Financial Results	NYSE:ABBV	AbbVie Inc
04/27/2021	8:30AM	PR Newswire (US)	Allergan, an AbbVie Company, to Share New Data Highlighting Latest Advancements in Eye Care at ARVO (Association for Research...	NYSE:ABBV	AbbVie Inc
04/23/2021	9:00AM	Dow Jones News	AbbVie Gets Positive EU Opinion on Leukemia Treatment	NYSE:ABBV	AbbVie Inc
04/23/2021	8:00AM	PR Newswire (US)	AbbVie Receives Positive CHMP Opinion for VENCLYXTO® (venetoclax) as a Combination Regimen for Adult Patients with Newly Dia...	NYSE:ABBV	AbbVie Inc
04/22/2021	10:59AM	Dow Jones News	AbbVie Gets Canada Approval of Humira in Pediatric Patients Ulcerative Colitis	NYSE:ABBV	AbbVie Inc
04/22/2021	10:05AM	PR Newswire (Canada)	AbbVie obtient l'approbation de Santé Canada pour l'emploi d'HUMIRA® (adalimumab) dans le traitement des enfants atteints d...	NYSE:ABBV	AbbVie Inc
04/22/2021	10:04AM	PR Newswire (Canada)	AbbVie Receives Health Canada Approval of HUMIRA® (adalimumab) for the Treatment of Pediatric Patients with Moderately to Se...	NYSE:ABBV	AbbVie Inc
04/20/2021	8:31AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ABBV	AbbVie Inc
04/19/2021	7:55PM	Dow Jones News	Drugmakers Accused of Causing Opioid Addiction in Trial -- Update	NYSE:ABBV	AbbVie Inc
04/19/2021	5:42PM	Dow Jones News	Drugmakers Accused of Causing Opioid Addiction in Trial	NYSE:ABBV	AbbVie Inc
04/15/2021	1:11PM	Edgar (US Regulatory)	Notice of Exempt Solicitation. Definitive Material. (px14a6g)	NYSE:ABBV	AbbVie Inc
04/07/2021	9:01AM	PR Newswire (US)	AbbVie Submits Regulatory Applications for SKYRIZI® (risankizumab) in Psoriatic Arthritis to FDA and EMA	NYSE:ABBV	AbbVie Inc
04/07/2021	8:00AM	PR Newswire (US)	AbbVie to Present Data Across its Robust Neuroscience Portfolio at the 2021 American Academy of Neurology (AAN) Annual Meetin...	NYSE:ABBV	AbbVie Inc
04/02/2021	6:23PM	Dow Jones News	FDA Extends Review of AbbVie's Skin Drug Application	NYSE:ABBV	AbbVie Inc
04/02/2021	5:18PM	PR Newswire (US)	AbbVie Announces Extension of Review for Supplemental New Drug Application of Upadacitinib for the Treatment of Moderate to S...	NYSE:ABBV	AbbVie Inc

Showing the most relevant articles for your search:NYSE:ABBV

<< Previous 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 Next >>

1812 Brewing (PK)

Impact Fusion (PK)

Ethema Health (PK)

Intergrated Cannabis Sol... (PK)

Anavex Life Sciences

ERHC Energy (CE)

Innovation Pharmaceuticals (CE)

Northwest Biotherapeutics (QB)

Kraig Biocraft Laborator... (QB)

Net Savings Link (PK)

Branded Legacy (PK)

Fannie Mae (QB)

Delayed Upgrade Clock